| 今开：5.55 | 昨收：5.58 |
| 最高：5.635 | 最低：5.35 |
| 涨停价： | 跌停价： |
| 总市值：5.7559607E7 |
Lantern Pharma(LTRN)04-27 09:45
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-053232 Act: 33 Size: 9 KB 网页链接查看全文
Lantern Pharma(LTRN)05-29 04:45
$Lantern Pharma(LTRN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-065619 Size: 25 KB 网页链接查看全文
Lantern Pharma(LTRN)03-19 04:15
$Lantern Pharma(LTRN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-010302 Act: 34 Size: 9 MB 网页链接查看全文
Lantern Pharma(LTRN)04-27 09:45
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-053229 Act: 33 Size: 9 KB 网页链接查看全文
Lantern Pharma(LTRN)05-10 04:15
$Lantern Pharma(LTRN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-24-018422 Act: 34 Size: 3 MB 网页链接查看全文
Lantern Pharma(LTRN)04-29 19:35
$Lantern Pharma(LTRN)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-016840 Act: 34 Size: 924 KB 网页链接查看全文
Lantern Pharma(LTRN)04-27 09:45
$Lantern Pharma(LTRN)$ 144 Report of proposed sale of securities Accession Number: 0001104659-24-053228 Act: 33 Size: 10 KB 网页链接查看全文
Lantern Pharma(LTRN)05-29 04:45
$Lantern Pharma(LTRN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-065616 Size: 36 KB 网页链接查看全文
Lantern Pharma(LTRN)05-25 04:15
$Lantern Pharma(LTRN)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-021347 Act: 33 Size: 1 MB 网页链接查看全文
Lantern Pharma(LTRN)03-19 04:15
$Lantern Pharma(LTRN)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001493152-24-010303 Act: 34 Size: 8 MB 网页链接查看全文
牛股小红书2022-01-13 10:55
$Lantern Pharma(LTRN)$ 宣布扩大与美国国立卫生研究院（National Institutes of Health）国家癌症研究所（NCI）的合作协议。
公司表示，这项合作的扩大是在确定了几个基因特征之后进行的，这些基因特征预测了患者肿瘤对Lantern的候选药物LP-184和LP-284的潜在反应。
LP-184作为一种新的...查看全文
$Lantern Pharma(LTRN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-20-014633 Size: 3 KB 网页链接
$Lantern Pharma(LTRN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-20-014635 Size: 4 KB 网页链接
$Lantern Pharma(LTRN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-20-014637 Size: 2 KB 网页链接
$Lantern Pharma(LTRN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-015994 Size: 26 KB 网页链接
$Lantern Pharma(LTRN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001813316-20-000001 Size: 32 KB 网页链接
$Lantern Pharma(LTRN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001789490-20-000004 Size: 43 KB 网页链接
$Lantern Pharma(LTRN)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-20-009332 Act: 33 Size: 6 MB 网页链接